Genetic Diversity of HIV-1 in Krasnoyarsk Krai: Area with High Levels of HIV-1 Recombination in Russia
Table 2
Characteristics of patients with HIV drug resistance mutations.
Code region of residence
Age (years)
Gender
Transmission risk group
HIV genotype†
Drug resistance mutations (NRTI)
Extent of ARVT (years NNRTI)
The level of ARVT compliance
Plasma HIV-1 RNA (copies/ml)††
CD4+ cell count (cells/mm3)††
7
Krasn.Krai
40
M
PWID
A6
M184V
K103N
5
High
598
376
9
Krasn. Krai
33
F
Not available
A6
A62V K65R V75I Y115F
G190S
2
High
8310
343
40
Krasnoyarsk
36
F
HTs
A6
M184V
K103N P225H
10
High
1170
598
61
Krasnoyarsk
58
F
HTs
A6
A62V K65R Y115F
V179DY181C
10
Low
2270000
32
73
Norilsk
46
M
HTs
A6
M184V
G190S K101Q
9
High
2703
265
74
Norilsk
43
M
HTs
A6
A62V D67E T69S_SA L210W T215F
K101E V179F Y181C Y188L V106I K238R
6
High
3906
84
75
Norilsk
47
M
HTs with PWID
A6
A62V K65R M184V
10
High
13304
183
77
Norilsk
35
M
PWID
URF63/A
M184V
K101E E138G G190S
6
Average
27596
54
79
Norilsk
36
M
PWID
URF02/A
M184 T215F
K101E G190S V90I V106I
6
Average
379
135
80
Norilsk
45
M
PWID
A6
K103N
7
Average
1490
322
102
Krasnoyarsk
36
F
HTs with PWID
A6
Y181C
6
Average
7030
23
107
Krasnoyarsk
39
F
HTs
A6
K65R
Y181C G190S K101Q
1
High
535000
239
109
Krasnoyarsk
37
M
PWID
A6
M184V T215F
G190S K101Q
7
High
52500
293
110
Krasn. Krai
38
F
HTs
A6
A62V D67G
E138K
3
Average
49500
473
131
Krasnoyarsk
45
M
PWID
URFA/B
K65R, Y115D
K103N Y181 V179I
1
Average
146000
123
149
Krasnoyarsk
39
F
HTs
A6
T215S
5
High
1640
296
150
Krasnoyarsk
38
M
PWID
A6
M184V
K103N P225H
6
Average
4930
307
583
Norilsk
39
M
PWID
A6
D67N K70R
A98G
10
High
1750
347
658
Norilsk
35
M
PWID
A6
A62V K70E M184V
K101E E138A G190S
8
Average
342143
120
3
Krasnoyarsk
36
M
HTs
А6
L74I M184V K219E
A98GY 181C G190S
6
Average
2600000
121
16.2
Krasn. Krai
33
F
HTs
А6
M41L L74I V75IM M184V T215S Q151M
K103N E138K G190S
4
High
201000
148
Gender: M: male; F: female. transmission risk group: PWID: people who inject drugs; HTs: people infected via heterosexual contacts. †HIV-1 genotype: the result of HIV-1 genotyping obtained after analysis of the complex of data: phylogenetic analysis from RP-RT, IN, and env regions and additional recombination analysis in case of inconsistency of genotyping results. The level of ARVT compliance was determined after individual interview with epidemiologist; ††plasma HIV-1 RNA and CD4+ cell count detected at the time of sampling of clinical blood samples.